Recurrent Mycosis Fungoides Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Mycosis fungoides recurrent

IndicationStatusPhase
DBCOND0080283 (Recurrent Mycosis Fungoides)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs